These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2574424)

  • 41. Non-opiate beta-endorphin fragments and dopamine-IV. gamma-Type endorphins may control dopaminergic systems in the nucleus accumbens.
    Van Ree JM; Wolterink G; Fekete M; De Wied D
    Neuropharmacology; 1982 Nov; 21(11):1119-27. PubMed ID: 6184641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Locomotor bias produced by intra-accumbens injection of dopamine agonists and antagonists.
    Messier C; Mrabet O; Destrade C
    Pharmacol Biochem Behav; 1992 Jan; 41(1):177-82. PubMed ID: 1347172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of amphetamine and apomorphine on locomotor activity after kainic acid lesion of the nucleus accumbens septi in the rat.
    Kafetzopoulos E
    Psychopharmacology (Berl); 1986; 88(3):271-4. PubMed ID: 3083447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypophysectomy-induced striatal hypersensitivity and mesolimbic hyposensitivity to apomorphine.
    Gordon JH
    Pharmacol Biochem Behav; 1983 Nov; 19(5):807-11. PubMed ID: 6139829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biphasic locomotor response to intra-accumbens dopamine in a nonhuman primate.
    Jones DL; Berg SL; Dorris RL; Dill RE
    Pharmacol Biochem Behav; 1981 Aug; 15(2):243-6. PubMed ID: 7198267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues.
    Sharp T; Bennett GW; Marsden CA; Tulloch IF
    Regul Pept; 1984 Nov; 9(4):305-15. PubMed ID: 6441196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of amphetamine and apomorphine on locomotor activity after 6-OHDA and electrolytic lesions of the nucleus accumbens septi.
    Kelly PH; Roberts DC
    Pharmacol Biochem Behav; 1983 Jul; 19(1):137-43. PubMed ID: 6413984
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced dopamine receptor activation in accumbens and frontal cortex has opposite effects on medial forebrain bundle self-stimulation.
    Olds ME
    Neuroscience; 1990; 35(2):313-25. PubMed ID: 2199840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uniquely, gamma-endorphin induces an effect that is both opiate- and neuroleptic-like.
    van Ree JM; Gaffori O
    Life Sci; 1983; 33 Suppl 1():619-22. PubMed ID: 6198576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens.
    Boldry RC; Uretsky NJ
    Neuropharmacology; 1988 Jun; 27(6):569-77. PubMed ID: 2901677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lesions of the dorsomedial nucleus of the thalamus, medial prefrontal cortex and pedunculopontine nucleus: effects on locomotor activity mediated by nucleus accumbens-ventral pallidal circuitry.
    Swerdlow NR; Koob GF
    Brain Res; 1987 Jun; 412(2):233-43. PubMed ID: 3607466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Competitive NMDA receptor antagonists do not produce locomotor hyperactivity by a dopamine-dependent mechanism.
    Ouagazzal A; Amalric M
    Eur J Pharmacol; 1995 Dec; 294(1):137-46. PubMed ID: 8788425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain.
    Jackson DM; Andén NE; Dahlström A
    Psychopharmacologia; 1975 Dec; 45(2):139-49. PubMed ID: 1215445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of SCH23390 injection into the dorsal striatum and nucleus accumbens on methamphetamine-induced gnawing and hyperlocomotion in rats.
    Koshikawa N; Mori E; Oka K; Nomura H; Yatsushige N; Maruyama Y
    J Nihon Univ Sch Dent; 1989 Jun; 31(2):451-7. PubMed ID: 2570826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stimulatory effect of N-methyl aspartate on locomotor activity and transmitter release from rat nucleus accumbens.
    Hamilton MH; De Belleroche JS; Gardiner IM; Herberg LJ
    Pharmacol Biochem Behav; 1986 Nov; 25(5):943-8. PubMed ID: 2878446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.
    Ichikawa J; Meltzer HY
    Brain Res; 1990 Jan; 507(1):138-42. PubMed ID: 2302571
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation by dopaminergic and serotonergic systems of cholinergic interneurons in nucleus accumbens and striatum.
    Bluth R; Langnickel R; Ott T
    Pol J Pharmacol Pharm; 1985; 37(6):753-63. PubMed ID: 3832017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of alpha 1-noradrenergic receptors demonstrated by in vivo voltammetry.
    Lane RF; Blaha CD; Rivet JM
    Brain Res; 1988 Sep; 460(2):398-401. PubMed ID: 2852047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Locomotor activity and the nucleus accumbens].
    Morgenstern R; Gold R; Oelssner W
    Biomed Biochim Acta; 1983; 42(7-8):947-53. PubMed ID: 6651811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Behavioral evidence for the involvement of endogenous opioids in the interaction between cholecystokinin and brain dopamine systems.
    Király I; Van Ree JM
    Neurosci Lett; 1987 Mar; 74(3):343-7. PubMed ID: 3561887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.